Plexus Q3 2025 slides: revenue tops $1 billion as operating margin hits 6% target

Plexus Corp (PLXS) reported robust fiscal Q3 2025 results, with revenue of $1.051 billion and non-GAAP EPS of $1.90, both exceeding its own guidance, while achieving its 6.0% operating margin target. The company demonstrated sequential growth across all market sectors, secured $250 million in new business wins, and significantly reduced total debt to $143 million. Looking ahead, Plexus provided Q4 2025 guidance with an EPS midpoint matching Q3's strong performance and expressed optimism for fiscal 2026, projecting 26% non-GAAP EPS growth for the full fiscal year 2025, underscoring its consistent execution and strong pipeline.

Analysis

Plexus Corp (PLXS) delivered a strong fiscal third-quarter 2025 performance, exceeding both revenue and earnings guidance while demonstrating significant operational and financial discipline. The company reported revenue of $1.051 billion, a 9.4% year-over-year increase, and achieved its target 6.0% non-GAAP operating margin. Non-GAAP EPS reached $1.90, comfortably beating the guidance range of $1.65 to $1.80. This outperformance was driven by broad-based sequential growth across all three of its market sectors—aerospace/defense (+6%), industrial (+4%), and healthcare/life sciences (+2%). The company's future growth prospects are supported by a 21.9% sequential increase in new business wins to $250 million and a robust manufacturing funnel of $3.612 billion. Financially, Plexus strengthened its balance sheet by reducing total debt from $210 million to $143 million and increased shareholder returns via $18.4 million in share repurchases. While free cash flow declined sequentially to $13.2 million, the company reaffirmed its projection to generate $100 million for the full fiscal year. Fourth-quarter guidance indicates sustained performance, with a non-GAAP EPS midpoint of $1.90, matching Q3's achievement and underpinning a forecast for 26% full-year EPS growth for fiscal 2025.

Key Decisions for Investors

• Given the strong earnings beat, broad-based sectoral growth, and a projected 26% full-year EPS growth, investors could view these results as confirmation of the company's operational excellence and market share gains.
• The combination of significant debt reduction and increased share repurchases highlights a disciplined capital allocation strategy that enhances shareholder value; continued execution toward the $100 million annual free cash flow target is a key metric to watch.
• Despite overall strength, investors should monitor the industrial sector for a recovery in semiconductor capital equipment and the healthcare sector's ability to overcome customer design delays to ensure momentum is maintained across all key revenue streams.